Charles Schwab Investment Management Inc Infla Rx N.V. Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$23.33 - $36.37 $1.08 Million - $1.68 Million	-46,310 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$29.34 - $35.0 $862,419 - $1.03 Million	29,394 Added 173.76%	46,310 $1.59 Million
Q2 2018 Aug 08, 2018	BUY	$27.33 - $41.46 $115,168 - $174,712	4,214 Added 33.18%	16,916 $546,000
Q1 2018 May 07, 2018	BUY	$20.21 - $32.0 $256,707 - $406,464	12,702 New	12,702 $367,000

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $77.4M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.